Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7796]

ESMO 2014: Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy

ESMO 2014: Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy

ESMO 2014: Access to breast cancer drug lacking in Eastern Europe

ESMO 2014: Access to breast cancer drug lacking in Eastern Europe

ESMO 2014: Canada and Europe sometimes years slower than USA in approving cancer drugs

ESMO 2014: Canada and Europe sometimes years slower than USA in approving cancer drugs

Ramucirumab gets go ahead from European Medicines Agency

Ramucirumab gets go ahead from European Medicines Agency

A way to kill chemo-resistant ovarian cancer cells: Cut down its protector

A way to kill chemo-resistant ovarian cancer cells: Cut down its protector

Adjusting treatment based on early response to chemo boosts survival in Philadelphia chromosome-like acute lymphoblastic leukaemia

Adjusting treatment based on early response to chemo boosts survival in Philadelphia chromosome-like acute...

Calming down immune cells could hold key to melanoma treatment

Calming down immune cells could hold key to melanoma treatment

Study identifies potential drug combination for mantle cell lymphoma and chronic lymphocytic leukaemia

Study identifies potential drug combination for mantle cell lymphoma and chronic lymphocytic leukaemia

Inhibitor of RNA polymerase I shows promise as potential treatment for acute myeloid leukaemia and multiple myeloma

Inhibitor of RNA polymerase I shows promise as potential treatment for acute myeloid leukaemia and multiple myeloma

Study finds a new approach to tackle drug resistance in haematologic malignancies

Study finds a new approach to tackle drug resistance in haematologic malignancies

More from ecancer